Note: Ingredients listed on restricted chemical lists
EC/CAS
236-675-5/13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
0.1-<1.0
EC/CAS
271-846-8/68609-97-2
Name of the chemical
Oxirane, mono[(C12-14-alkyloxy)methyl] derivs
Concentration
0.1 - <1.0
General Information
Version
3
Revision date
2023-09-05
Product name
CARBOTHERM 551 PART A Supercedes Date: 07/11/2022
supplier name
Tarka, Malgorzata
Manufacturer Name
Carboline Norge AS
Emergency telephone
+1 703 5273887, +3851 2348 342
Icons in SDS
Company Information
company name
Carboline Norge AS
e-mail address of the competent person responsible for the Safety Data Sheet
hms@carboline.com
GHS Information
Signal word
Warning
Section 2
SECTION 2: Hazards identification
Hazard statements
Allergic effects EUH208 Allergic effects EUH208
Additional information
ADD-09 Based on available information the product does not meet the classification criteria in accordance with CLP. ADD-12 Contains poly(bisphenol a-co-epichlorohydrin), glycidyl end- capped, Oxirane, mono[(C12-14-alkyloxy)methyl] derivs. May produce an allergic reaction.
2.2 Label elements
Symbol(s) of Product None
Signal word
Warning Named Chemicals on Label None
Contains
Oxirane, mono[(C12-14-alkyloxy)methyl] derivs May produce an allergic reaction. Other EU extensions EUH211 Warning! Hazardous respirable droplets may be formed when sprayed. Do not breathe spray or mist.
Precautionary statements
P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P280 Wear protective gloves/protective clothing/eye protection/ face protection. P333+313 If skin irritation or rash occurs: Get medical advice/attention.
2.3 Other hazards
No Information
Results of PBT and vPvB assessment
The product does not meet the criteria for PBT/vPvB in accordance with Annex XIII. Endocrine disrupting properties - Toxicity Based on the available data, the product does not contain substances identified as having endocrine disrupting properties according to Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 in concentration of 0,1% or higher. Endocrine disrupting properties - Ecotoxicity Based on the available data, the product does not contain substances identified as having endocrine disrupting properties according to Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 in concentration of 0,1% or higher.
